Cervical Cancer Detection using bimodal Imaging Technique
Phase 2
Completed
- Conditions
- Health Condition 1: N879- Dysplasia of cervix uteri, unspecifiedHealth Condition 2: N72- Inflammatory disease of cervix uteriHealth Condition 3: N880- Leukoplakia of cervix uteriHealth Condition 4: N870- Mild cervical dysplasiaHealth Condition 5: N871- Moderate cervical dysplasia
- Registration Number
- CTRI/2020/09/027999
- Lead Sponsor
- Phebe George
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 109
Inclusion Criteria
1.Patients referred for Pap smear test
2.Patients with any kind of clinically suspected lesions in uterine cervix
Exclusion Criteria
1.Patients who had undergone previously treatments for cancer
2.Patients with transmittable diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Patients will have possibility to get a more accurate screening for cervical cancer using cerviscan. <br/ ><br>2.location of most malignant site for biopsy using cerviscan helps to minimize false negatives unnecessary biopsiesTimepoint: One week
- Secondary Outcome Measures
Name Time Method Identification of areas of inflammationTimepoint: 1 week